EU medtech notified bodies tackle unannounced inspections in updated code
This article was originally published in Clinica
Executive Summary
The European association of medtech notified bodies, Team-NB, has adopted a revised code of conduct with a new section calling for unannounced inspections of device manufacturers once every three years at least. Compliance with these specific recommendations will be voluntary for the foreseeable future; they will only become officially applicable for Team-NB members once new legal requirements mandating unannounced inspections come into force – and this will not happen for several years.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.